Immuneering Corporation
IMRX
$1.45
-$0.01-0.69%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -61.04M | -58.07M | -56.07M | -54.18M | -53.47M |
| Total Depreciation and Amortization | 385.00K | 388.70K | 378.00K | 365.80K | 352.10K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 6.58M | 6.15M | 5.74M | 5.34M | 5.13M |
| Change in Net Operating Assets | -925.40K | -733.50K | -870.60K | -1.57M | -974.60K |
| Cash from Operations | -55.00M | -52.26M | -50.82M | -50.04M | -48.97M |
| Capital Expenditure | -85.00K | -246.50K | -298.30K | -352.20K | -342.70K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 26.52M | 24.32M | 5.82M | 10.07M | 7.64M |
| Cash from Investing | 26.43M | 24.08M | 5.52M | 9.72M | 7.30M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 5.43M | 5.35M | 1.01M | 29.39M | 28.64M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -127.40K | 0.00 | 0.00 | -203.80K | -203.80K |
| Cash from Financing | 5.30M | 5.35M | 1.01M | 29.18M | 28.44M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -23.26M | -22.83M | -44.29M | -11.14M | -13.23M |